Close

Kidney Stones

Open
  • Results are currently sorted by date (Sort results by:  relevance)
  • Results 1 - 10 (of 49)
  • 
  • Frusene Tablets - Summary of Product Characteristics

    ...including case reports) Interstitial nephritis, urinary stones General disorders and administration site conditions Rare...is 0.1 to 0.2 l/kg. Furosemide is metabolised in the kidney by glucuronic acid conjugation and excreted in the urine and...

    electronic Medicines Compendium, 08 October 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Topiramate Actavis 15mg Capsules, hard - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 18 September 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Topiramate Actavis 25mg Capsules, hard - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 29 August 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

    ...therapies in ovarian cancer more information Rebecca L Stone,Anil K Sood,Robert L Coleman. The Lancet Oncology 1 May...1810 Newsdesk Bevacizumab and erlotinib show promise for kidney cancer more information Heather Lindsey. The Lancet Oncology...

    28 August 2014 - Publisher: The Lancet Oncology - Publication type: Randomised controlled trials

  • Topiramate 100 mg film-coated Tablets - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 05 August 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Topiramate 50 mg capsules, hard - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 05 August 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Topiramate 50 mg film-coated Tablets - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 05 August 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Topiramate 200 mg film-coated Tablets - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 05 August 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Topiramate 25 mg film-coated Tablets - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 05 August 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

  • Topiramate 25 mg capsules, hard - Summary of Product Characteristics

    ...nephrolithiasis, may be at increased risk for renal stone formation and associated signs and symptoms...factors for nephrolithiasis include prior stone formation, a family history of nephrolithiasis...these risk factors can reliably predict stone formation during topiramate treatment...

    electronic Medicines Compendium, 05 August 2014 - Publisher: electronic Medicines Compendium (eMC), Datapharm Communications Ltd - Publication type: Summary of Product Characteristics

Results 1 - 10 (of 49)
loading